Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Sandoz Doesn’t Need Biosimilars Purchases, Chief Tells Finanz

June 9 (Bloomberg) -- Novartis AG’s Sandoz unit doesn’t need acquisitions in the biosimilars business, Finanz und Wirtschaft reported, citing an interview with Jeff George, who heads the unit.

George said he expects a “shakeout” in the market as some smaller companies lack the technological abilities and commercial understanding needed to bring about sophisticated biosimilars, the newspaper reported.

To contact the reporter on this story: Elena Logutenkova in Zurich at

To contact the editor responsible for this story: Frank Connelly at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.